Mesoblast
Mesoblast is a medicine company that develops biologic products for the broad field of regenerative medicine.
Raised 110M EQUITY on March 2, 2021
About
Mesoblast is an Australian biotechnology company that develops stem-cell therapies.
Mission
Mesoblast is described in the article as an Australian company that develops stem cell therapies. The piece characterizes Mesoblast as a stem‑cell therapy player that faced rough waters in 2020. It reports the company was given a financial lifeline when it raised $110 million. The article does not provide product-level detail, pipeline specifics, operating metrics, or stated future plans. The report also does not disclose the financing instrument or the terms of the transaction. Coverage frames the cash infusion as a lifeline for the company.
Quick Facts
Founded
2004
Funding
EQUITY
Industry
Biotechnology, Health Care, Health Diagnostics
Team Size
51-100
Headquarters
Melbourne, Victoria, Australia
Careers
View Careers Page
Mesoblast
https://jobs.ashbyhq.com/mesoblastNo open roles at this time.
Check their careers page for updates